Delivery Order SPE2DX22D0010-SPE2D826FAA48
- Not listed
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Nucynta ER Tabs 250mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order, valued at $8,619.04 with an ultimate completion date of June 2, 2025, represents a non-competitive award executed under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Nucynta 75 mg tablets (100-count units) valued at $30,223.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. The contract ceiling value is $5,313.94, with an ultimate completion date of October 1, 2025. This is a non-set-aside award issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,843.64 with firm fixed pricing and is scheduled for completion by September 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,315.96 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg, a pain management pharmaceutical. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,375.14 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,205.75 firm fixed-price delivery order by the Defense Logistics Agency on June 2, 2025, for Nucynta ER 200 mg tablets (60-count supply). The contract, which carries an ultimate completion date of June 3, 2025, represents a non-competitive award and serves the federal medical supply chain supporting military and veteran healthcare systems. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,268.26. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement extending through December 2026. The place of performance is listed...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAA48Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $11,313.88 delivery order to AmerisourceBergen Drug Corp on October 1, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitive, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal procurement processes. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to serve as a comprehensive pharmaceutical supplier for military healthcare programs globally, supporting the Defense Health Agency and other federal health systems. The company's extensive federal contract portfolio demonstrates its role as a critical vendor for federal medical procurement, particularly for pharmaceutical products spanning multiple therapeutic domains including pain management, neurology, endocrinology, and specialty medications required by military and veteran healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 10/1/25 |